Predicting Heart Failure and Death in People With Left Bundle Branch Block
Studies heart scans and ECG features to predict outcomes in left bundle branch block.
Plain-language title generated from the registry record
Registry title: Prediction of Outcome by Echocardiography in Left Bundle Branch Block
Key facts
- Where
- Tromsø, NorwaySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT04293471, who can take part
Where in Norway
- University Hospital North NorwayTromsø, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital of North Norway
- Trial code
- NCT04293471
- Record updated
- 24 May 2022
- Original description
Patients with left bundle branch block have an increased risk for the development of heart-failure and death. However, risk factors for unfavorable outcomes are still poorly defined. This study aims to identify echocardiographic parameters and ECG characteristics by machine learning in order to develop individual risk assessmentRead full original descriptionShow less
Prediction of Heart-failure and Mortality by Echocardiographic Parameters and Machine Learning in Individuals With Left Bundle Branch Block
Patients with left bundle branch block have an increased risk for the development of heart-failure and death. However, risk factors for unfavorable outcomes are still poorly defined. This study aims to identify echocardiographic parameters and ECG characteristics by machine learning in order to develop individual risk assessment
Inclusion: QRS complex >130 ms and R-wave duration in; V6 >70 ms; ventricular pacing>50%; Previously implanted cardiac resynchronisation therapy (CRT).
Exclusion: patients with complex congenital heart disease; Typical right bundle branch block; No ability to give informed consent,; non-cardiovascular co-mobidities with reduced life-expectancy < 1 year.